Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Neurolysis in Advanced Hip Osteoarthritis
NCT06087588Phase 4Completed
- Sponsor
- Poznan University of Medical Sciences
- Start
- Oct 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ethanol in osteoarthritis (OA) (2 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Numeric Rating Scale at 6 months. Started Oct 2023; status: completed.
02
Drugs
ethanol
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06087588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06087588.